NASDAQ:PETSPetmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PETS stock has increased by 21.8% and is now trading at $31.62.
View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) released its earnings results on Monday, July, 20th. The company reported $0.39 EPS for the quarter, missing the Zacks' consensus estimate of $0.40 by $0.01. The business earned $96.20 million during the quarter, compared to the consensus estimate of $90.96 million. Petmed Express had a return on equity of 21.91% and a net margin of 9.41%. The company's revenue was up 20.3% on a year-over-year basis. During the same period last year, the firm earned $0.26 earnings per share.
View Petmed Express' earnings history.

Petmed Express declared a quarterly dividend on Monday, July 20th. Shareholders of record on Friday, July 31st will be paid a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 annualized dividend and a yield of 3.54%. The ex-dividend date is Thursday, July 30th.
View Petmed Express' dividend history.

2 brokers have issued 12 month target prices for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' share price to reach $25.50 in the next year. This suggests that the stock has a possible downside of 19.4%.
View analysts' price targets for Petmed Express.

Headlines about PETS stock have been trending positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Petmed Express earned a coverage optimism score of 2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Petmed Express.

Petmed Express saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 6,060,000 shares, an increase of 7.8% from the June 15th total of 5,620,000 shares. Based on an average trading volume of 629,200 shares, the days-to-cover ratio is currently 9.6 days. Currently, 31.2% of the shares of the company are sold short.
View Petmed Express' Current Options Chain.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Overstock.com (OSTK), Tripadvisor (TRIP), 1-800-Flowers.Com (FLWS), Shutterfly (SFLY), U.S. Auto Parts Network (PRTS) and Groupon (GRPN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Cisco Systems (CSCO), Netflix (NFLX), Verizon Communications (VZ), Micron Technology (MU) and Advanced Micro Devices (AMD).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (1.74%), ProShare Advisors LLC (1.19%), WINTON GROUP Ltd (1.12%), Principal Financial Group Inc. (0.75%), Raymond James Financial Services Advisors Inc. (0.65%) and Profit Investment Management LLC (0.42%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., Profit Investment Management LLC, Wedge Capital Management L L P NC, Smith Asset Management Group LP, and Genesee Capital Advisors LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express.

PETS stock was purchased by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Mackay Shields LLC, WINTON GROUP Ltd, SG Americas Securities LLC, Jennison Associates LLC, and UBS Group AG.
View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $31.62.

Petmed Express has a market capitalization of $641.00 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.